Leveraging Intelligent Tech for Drug Development
 Real-Case Scenarios for Accelerating Drug Discovery and Modernizing Clinical Trials with Data & Automation

September 30, 2020 | Live Virtual Forum (EST)

Ashley Zehnder

Founder, CEO Fauna Bio

Prior to starting Fauna Bio, Ashley’s research focused on translational science and veterinary informatics at Stanford, earning a PhD in Cancer Biology and her work spans >20 peer-reviewed publications, including Cell, Nature and Nature Medicine and several book chapters. She is a boarded avian veterinarian with specialty training in exotic/non-traditional species. She is a co-founder of the Exotic Species Cancer Research Alliance and incoming president of the Association of Avian Veterinarians.

WEDNESDAY, SEPTEMBER 30

10:15 AM Breakout Networking & Informal Discussion: Early Stage Development, Capital & Financing

Moderated, Informal Networking Discussion on Perspectives on Early Stage Financing, Venture Capital & Investments in AI, Automation & Data Based Biotech